Oligodendrocyte Lineage in Multiple System Atrophy

Oligodendrocyte Lineage in Multiple System Atrophy

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Oligodendrocyte Lineage in Multiple System Atrophy</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000128](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000128)</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>MSA</td>
</tr>
<tr>
<td class="label">Main synuclein site</td>
<td>Oligodendrocytes</td>
</tr>
<tr>
<td class="label">Inclusion type</td>
<td>GCI</td>
</tr>
<tr>
<td class="label">Myelin loss</td>
<td>Severe</td>
</tr>
</table>

Oligodendrocyte Lineage In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Oligodendrocyte Lineage in Multiple System Atrophy

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Oligodendrocyte Lineage in Multiple System Atrophy</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000128](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000128)</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>MSA</td>
</tr>
<tr>
<td class="label">Main synuclein site</td>
<td>Oligodendrocytes</td>
</tr>
<tr>
<td class="label">Inclusion type</td>
<td>GCI</td>
</tr>
<tr>
<td class="label">Myelin loss</td>
<td>Severe</td>
</tr>
</table>

Oligodendrocyte Lineage In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Multiple System Atrophy (MSA) is characterized by progressive oligodendroglial degeneration with the formation of glial cytoplasmic inclusions (GCIs). These inclusions contain aggregated alpha-synuclein, making MSA distinct from other synucleinopathies. The oligodendroglial pathology is central to disease pathogenesis and drives the white matter dysfunction and neurodegeneration seen in MSA. [@jellinger2014]

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: oligodendrocyte (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:0000128)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000128)
• [OBO Foundry (CL:0000128)](http://purl.obolibrary.org/obo/CL_0000128)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Markers

Mature Oligodendrocytes

• MBP (Myelin Basic Protein) - structural myelin protein
• PLP1 (Proteolipid Protein 1) - major myelin protein
• MOG (Myelin Oligodendrocyte Glycoprotein) - surface marker
• CNP (2',3'-Cyclic Nucleotide 3'-Phosphodiesterase) - enzyme marker
• OLIG2 - oligodendrocyte transcription factor 2
• SOX10 - transcription factor for oligodendrocyte lineage

GCI-Associated Proteins

• SNCA (Alpha-synuclein) - GCI main component
• p25α (PPP1R2A) - tubulin polymerization regulator
• HSP90 - heat shock protein
• Ubiquitin - inclusion marker
• TPPP/p25 - GCI-specific protein

Anatomy and Distribution

White Matter Regions Affected

• Striatonigral system: Putamen, caudate
• Cerebellar white matter: Middle cerebellar peduncle
• Brainstem: Pontine fibers
• Spinal cord: Lateral columns
• Cerebral white matter: Subcortical regions

Oligodendrocyte Subtypes

• Internodal oligodendrocytes: Myelinate long axons
• Perineuronal oligodendrocytes: Surround neuron cell bodies
• Vascular oligodendrocytes: Associated with blood vessels

Pathology in MSA

Glial Cytoplasmic Inclusions (GCIs)

• Shape: Flame-shaped, tapered ends
• Location: Cell body and processes
• Composition: Alpha-synuclein filaments
• Distribution: Throughout white matter
• Prevalence: >90% of cases

Myelin Pathology

• Myelin loss: Vacuolation, fragmentation
• Demyelination: Primary pathway
• Remyelination attempts: In early stages
• Oligodendrocyte death: Progressive

Comparison with Other Disorders

Vulnerability Mechanisms

1. Alpha-Synuclein Pathogenesis

• GCI formation: Oligodendroglial alpha-synuclein aggregation
• Propagation: Neuron-to-oligodendrocyte transmission
• Impaired clearance: [Autophagy](/entities/autophagy) deficits
• Oxidative stress: Enhances aggregation

2. Myelin Dysfunction

• Metabolic stress: Impaired oligodendrocyte function
• Iron accumulation: Promotes oxidative damage
• Lipid peroxidation: Myelin breakdown
• Energy failure: Mitochondrial dysfunction

3. Neuroinflammation

• Microglial activation: Surrounding white matter
• Cytokine release: TNF-α, IL-1β
• Complement activation: Myelin elimination
• Astrocyte reactivity: In GCI-rich areas

4. Axonal Degeneration

• Secondary to demyelination: Energy deficits
• Primary oligodendrogliopathy: Driving force
• Dystrophic axons: In GCI regions

Clinical Implications

Motor Symptoms

• Parkinsonism: Bradykinesia, rigidity
• Cerebellar ataxia: Gait instability
• Autonomic failure: Orthostatic hypotension
• Stridor: Laryngeal dysfunction

Non-Motor Symptoms

• Cognitive impairment: Executive dysfunction
• Sleep disorders: REM behavior disorder
• Depression: Common in MSA

Therapeutic Implications

Current Approaches

• Symptomatic treatment: Dopaminergic medications
• Autonomic management: Fludrocortisone, midodrine
• Physical therapy: Maintain function

Disease-Modifying Strategies

• Alpha-synuclein targeting: Immunotherapy
• Myelin protection: Promote oligodendrocyte survival
• Neurotrophic support: GDNF delivery
• Anti-inflammatory agents: Microglial modulation

Background

The study of Oligodendrocyte Lineage In Multiple System Atrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/mechanisms/alpha-synuclein)
• [/mechanisms/app-processing](/mechanisms/app-processing)
• [/mechanisms/amyloid-aggregation](/mechanisms/amyloid-aggregation)
• [/mechanisms/microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Oligodendrocytes](/cell-types/oligodendrocytes)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Glial Cytoplasmic Inclusions](/mechanisms/gci-pathology)

Pathway Diagram

The following diagram shows the key molecular relationships involving Oligodendrocyte Lineage in Multiple System Atrophy discovered through SciDEX knowledge graph analysis: